List of Recent Awards
| Brian Ackley | Ultrastructural analysis of synaptic degeneration in rapidly developing AD models level | J.R. & Inez Jay Fund | $20,000 | 07/01/2022 |
| Yoshiaki Azuma | Specific Chromatin Interaction of DNA Topoisomerase II Isoforms and its Role on Regulation of their Cellular Function | University of Kansas Medical Center Research Institute | $10,000 | 07/01/2022 |
| David Davido | Identifying regions in HSV-1 that contribute to neuroinvasiveness | J.R. & Inez Jay Fund | $20,000 | 07/01/2022 |
| Anthony Fehr | Discovery and Optimization of SARS-CoV-2 Mac1 Inhibitors | J.R. & Inez Jay Fund | $20,000 | 07/01/2022 |
| Lan Guo | Mitochondrial DNA oxidative damages and microglial activation in Alzheimer's disease | BrightFocus Foundation | $300,000 | 07/01/2022 |
| David Johnson | PTPRD phosphatase inhibitors for stimulant use disorders | University of Maryland | $26,775 | 07/01/2022 |
| Sue Lunte | Molecular Analysis of Disease Pathways | National Institutes of Health | $5,737,500 | 07/01/2022 |
| Kristi Neufeld | Cancer Center Support Grant - Cancer Biology Program | University of Kansas Medical Center Research Institute | $28,949 | 07/01/2022 |
| Eduardo Rosa-Molinar | Neuroglial Tumor Synapse Revisited | University of Kansas Medical Center Research Institute | $10,000 | 07/01/2022 |
| Shyam Sathyamoorthi | Syntheses and Biological Evaluation of Underexplored Antibiotics and Analogues | University of Kansas Medical Center Research Institute | $25,000 | 07/01/2022 |
| Jingxin Wang | Systematic identification of splicing-modulating regulatory elements | W.M. Keck Foundation | $1,200,000 | 07/01/2022 |
| Jingxin Wang | Down-regulation of Interferon Signaling by Splicing Modulators | University of Kansas Medical Center Research Institute | $25,000 | 07/01/2022 |
| Dan Dixon | Cancer Center Support Grant - Drug Discovery Delivery and Experimental Therapeutics Component (D3ET) | University of Kansas Medical Center Research Institute | $31,539 | 07/26/2022 |
| Laird Forrest | Personalized T Cell Therapy for Mantle Cell Lymphoma | University of Kansas Medical Center Research Institute | $35,000 | 07/26/2022 |
| Michael Johnson | Sub-cellular Neurotransmitter Population Dynamics in Chemobrain | University of Kansas Medical Center Research Institute | $35,000 | 07/26/2022 |
| Steven Bloom | New catalytic strategies to make non-proteinogenic peptides | National Institutes of Health | $1,912,500 | 08/01/2022 |
| Amy Burgin | Bridges to the Baccalaureate Research Training Program at the University of Kansas/Haskell Indian Nations University | National Institutes of Health | $1,233,748 | 08/01/2022 |
| Jingxin Wang | Modulating gene expression by RNA-targeting chimeras | National Institutes of Health | $1,912,500 | 08/01/2022 |
| Cory Berkland | Development of SAgA-T1D as Type 1 Diabetes Antigen Specific Immunotherapy | Helmsley Charitable Trust | $3,005,839 | 09/01/2022 |
| Dan Dixon | In vivo model for assessment of intestinal adenoma-derived extracellular vesicles | University of Kansas Medical Center Research Institute | $25,000 | 09/01/2022 |
| Scott Hefty | Functional Genomics for Chlamydia | University of Washington | $275,468 | 09/01/2022 |
| Joanna Slusky | MFB: NSF-BSF: Data-Adaptive and Metamorphosis Machine Learning Architectures for Generative Protein Design of Metal Biosensors | National Science Foundation | $1,500,000 | 09/01/2022 |
| Laird Forrest | Development of a tumor-retentive immunostimulant as adjunct therapy for solid tumor cancers | Kinimmune | $160,182 | 09/07/2022 |
| Kristi Neufeld | Roles for Adenomatous polyposis coli in colon injury prevention and wound healing | National Institutes of Health | $1,104,185 | 09/22/2022 |
| Christian Schöneich | Kinetics of methionine oxidation in peptides | AbbVie Inc. | $50,000 | 10/26/2022 |
| Christian Schöneich | SubQ Application of Biologics - in vivo degradation in the SubQ space as impact factor for reduced bioavailability | Novartis Pharma AG | $310,000 | 11/22/2022 |
| Anthony Fehr | Identifying the targets of virus-induced PARPs during SARS-CoV-2 infection | National Institutes of Health | $424,184 | 12/22/2022 |